Viewing StudyNCT04740424



Ignite Creation Date: 2024-05-06 @ 3:46 PM
Last Modification Date: 2024-10-26 @ 1:56 PM
Study NCT ID: NCT04740424
Status: RECRUITING
Last Update Posted: 2024-05-13
First Post: 2021-01-28

Brief Title: FS222 First in Human Study in Patients With Advanced Malignancies
Sponsor: invoX Pharma Limited
Organization: invoX Pharma Limited

Conditions & Keywords Data

Conditions:
Name
Advanced Cancer
Metastatic Cancer
Keywords:
Name View
Immunotherapy View
Immuno-oncology View
bispecific antibody View
dose escalation View
cohort expansion View
CD137 View
PD-L1 View
F-star View
4-1BB View